At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 121 enrolled
Drug / intervention
Hydrocodone/acetaminophen +4 moredrug
Likely dose
Hydrocodone/acetaminophen 325mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Evaluation of Hydrocodone/Acetaminophen for Pain Control in First Trimester Surgical Abortion
In Brief
A Phase 4 clinical trial evaluating Hydrocodone/acetaminophen, Placebo, and 3 other interventions for Pain. Completed, enrolled 121 participants across 2 sites.
Detailed Summary
The purpose of this study is to determine whether preoperatively administered hydrocodone/acetaminophen (HC/APAP) reduces pain during a first trimester surgical abortion.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited States
CollaboratorsPlanned Parenthood Federation of America
Timeline
Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2011
First PostedApr 2011
Primary CompletionOct 2011
TodayJul 2026
First PostedApr 7, 2011
Enrollment StartFeb 1, 2011
Primary CompletionOct 1, 2011
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 15.2 years ago
Interventions
Hydrocodone/acetaminophendrug
Administration of 2 tablets 5/325mg hydrocodone/acetaminophen 45-90 minutes prior to procedure.
Placebodrug
Administration of 2 tablets methylcellulose (placebo) 45-90 minutes prior to procedure.
Ibuprofendrug
800 mg oral ibuprofen
Lorazepamdrug
2 mg oral lorazepam
Lidocainedrug
20 ml 1% buffered lidocaine, injected